Potential tissue bids emerge as Essity stock awaits results
Published on 10/20/2026 at 10:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTissue review and earnings date
- Potential bidders were linked to Essity's consumer tissue review on October 16, 2026, with a reported value of EUR 3.0 billion.
- Nordea raised its price target to SEK 315 from SEK 300 on October 15, 2026.
- Essity B stock trades at EUR 24.83 at 10:37 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.04 percent above the Xetra close of October 19, 2026.
Essity B stock (ISIN SE0009922164) was trading at EUR 24.83 at Lang & Schwarz on October 20, 2026, at 10:37 a.m. CEST, 0.04 percent above the Xetra close of October 19, 2026 at EUR 24.82. The immediate company catalyst is a reported interest in Essity's consumer tissue business before the third-quarter report.
As MarketScreener reported on October 16, 2026, Asia Pulp & Paper and CVC Capital Partners were considering separate bids for the business. The report put a possible value of EUR 3.0 billion on the unit, while Essity's strategic review continued and all options remained under consideration.
What bidders mean for tissue
The potential transaction gives the upcoming results a second dimension beyond quarterly earnings. Consumer tissue includes brands such as Cushelle, Tempo and Tork, according to the October 16, 2026 report linked above. Any separation would change the group's portfolio mix and make the treatment of proceeds a central investor question.
Three dates shaped the setup
On October 1, 2026, BNP Paribas cut its Essity target to SEK 265 from SEK 275, according to Affarsvarlden. On October 15, 2026, Nordea raised its target to SEK 315 from SEK 300, as MarketScreener reported. The October 16 tissue-bid report is the latest event in this sequence.
When is the next report?
Essity's investor-relations page schedules the third-quarter 2026 interim report for October 22, 2026, at approximately 7:00 a.m. CET, followed by a presentation at 9:00 a.m. CET. That date makes cost pressure and margin performance the next measurable test for the investment case. Barclays expects third-quarter revenue of SEK 36.478 billion and adjusted EBITA of SEK 4.618 billion, or a 12.7 percent margin, versus consensus of SEK 4.414 billion and 12.2 percent, according to MarketScreener.
Stock price and investor frame
Essity B stock was trading at EUR 24.83 at Lang & Schwarz on October 20, 2026, at 10:37 a.m. CEST, 0.04 percent above the Xetra close of October 19, 2026 at EUR 24.82. The next report must reconcile the margin debate with the strategic review and the competing analyst targets.
The further course of trading is shown by the continuously updated real-time quote of Essity B stock.
Essity B stock facts
- Company: Essity Aktiebolag (publ)
- ISIN: SE0009922164
- Ticker: ESSITY-B.ST
- Primary exchange: Nasdaq Stockholm
- Price Lang & Schwarz (as of October 20, 2026, 10:37 a.m. CEST): EUR 24.83
- Change versus Xetra close: plus 0.04 percent
- Xetra close (October 19, 2026): EUR 24.82
- Sector / Industry: Consumer staples / household products
Market context: Market report OMXS30.
